Year: 2025
Type: article
Abstract: Can Trump really lower US drug prices and raise them in other countries? Probably not Owen DyerDrug industry stock prices dropped when Donald Trump announced his intention to lower drug prices through executive decree, but in the end the markets had the final word.Share prices fell in early trading on 12 May, after the US president teased a forthcoming announcement that was "as big as it gets"-and hinted on his Truth Social platform that his scheme involved limiting US drug prices to match the lowest prices paid in other wealthy countries.As his executive order was unveiled, 1 however, stocks in the drug market reversed their slide, and several large manufacturers finished the day with gains of more than 5%."Better than feared," wrote analysts at the Wall Street bank Jefferies in a note to investors."More bark than bite," concluded analysts at TD Cowen.Health policy experts were broadly dismissive."The executive order reads more like an aspirational statement than a serious attempt to initiate a policy change," Ameet Sarpatwari of Harvard Medical School told the New York Times.Stacie Dusetzina, health policy professor at Vanderbilt University, commented, "It almost sounds like: 'We'll just ask for lower prices and see how that goes.'"
Source: BMJ
DOI: 10.1136/bmj.r1142
Author: Owen Dyer
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: bronze
OpenAlex ID: W4411077827